Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tomas Maira-Litran, Ph.D.

Other Positions

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R41AI118037 (MAIRA-LITRAN, TOMAS) Feb 1, 2015 - Jan 31, 2018
    Lipoprotein synthesis inhibitors for multi-drug resistant Gram-negative therapy
    Role: Principal Investigator
  2. R21AI073586 (MAIRA-LITRAN, TOMAS) Dec 15, 2007 - Nov 30, 2010
    Multi-componet Vaccine for Staphylcoccus epidermidis
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sanchez-Larrayoz AF, Elhosseiny NM, Chevrette MG, Fu Y, Giunta P, Spallanzani RG, Ravi K, Pier GB, Lory S, Maira-Litrán T. Complexity of Complement Resistance Factors Expressed by Acinetobacter baumannii Needed for Survival in Human Serum. J Immunol. 2017 10 15; 199(8):2803-2814. PMID: 28855313.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  2. Maira-Litrán T. Immunization of Mice. Curr Protoc Mol Biol. 2017 01 05; 117:11.4.1-11.4.11. PMID: 28060409.
    Citations: 1     Fields:    Translation:AnimalsPHPublic Health
  3. Song J, Wilhelm CL, Wangdi T, Maira-Litran T, Lee SJ, Raetz M, Sturge CR, Mirpuri J, Pei J, Grishin NV, McSorley SJ, Gewirtz AT, Bäumler AJ, Pier GB, Galán JE, Yarovinsky F. Absence of TLR11 in Mice Does Not Confer Susceptibility to Salmonella Typhi. Cell. 2016 Feb 25; 164(5):827-8. PMID: 26919416.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  4. França A, Carvalhais V, Maira-Litrán T, Vilanova M, Cerca N, Pier G. Alterations in the Staphylococcus epidermidis biofilm transcriptome following interaction with whole human blood. Pathog Dis. 2014 Apr; 70(3):444-8. PMID: 24391077.
    Citations: 7     Fields:    Translation:HumansCells
  5. Cywes-Bentley C, Skurnik D, Zaidi T, Roux D, Deoliveira RB, Garrett WS, Lu X, O'Malley J, Kinzel K, Zaidi T, Rey A, Perrin C, Fichorova RN, Kayatani AK, Maira-Litràn T, Gening ML, Tsvetkov YE, Nifantiev NE, Bakaletz LO, Pelton SI, Golenbock DT, Pier GB. Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):E2209-18. PMID: 23716675.
    Citations: 68     Fields:    Translation:HumansAnimalsCells
  6. Maira-Litrán T, Bentancor LV, Bozkurt-Guzel C, O'Malley JM, Cywes-Bentley C, Pier GB. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A. PLoS One. 2012; 7(9):e43813. PMID: 22970144.
    Citations: 15     Fields:    Translation:AnimalsCells
  7. Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T. Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun. 2012 Oct; 80(10):3381-8. PMID: 22825448.
    Citations: 49     Fields:    Translation:AnimalsCells
  8. Bentancor LV, Camacho-Peiro A, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Identification of Ata, a multifunctional trimeric autotransporter of Acinetobacter baumannii. J Bacteriol. 2012 Aug; 194(15):3950-60. PMID: 22609912.
    Citations: 50     Fields:    Translation:AnimalsCells
  9. Skurnik D, Davis MR, Benedetti D, Moravec KL, Cywes-Bentley C, Roux D, Traficante DC, Walsh RL, Maira-Litràn T, Cassidy SK, Hermos CR, Martin TR, Thakkallapalli EL, Vargas SO, McAdam AJ, Lieberman TD, Kishony R, Lipuma JJ, Pier GB, Goldberg JB, Priebe GP. Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection. J Infect Dis. 2012 Jun; 205(11):1709-18. PMID: 22448004.
    Citations: 19     Fields:    Translation:AnimalsCells
  10. Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Poly-N-acetyl-ß-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun. 2012 Feb; 80(2):651-6. PMID: 22104104.
    Citations: 40     Fields:    Translation:AnimalsCells
  11. Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infect Immun. 2011 Aug; 79(8):3455-64. PMID: 21628521.
    Citations: 15     Fields:    Translation:AnimalsCells
  12. Skurnik D, Merighi M, Grout M, Gadjeva M, Maira-Litran T, Ericsson M, Goldmann DA, Huang SS, Datta R, Lee JC, Pier GB. Animal and human antibodies to distinct Staphylococcus aureus antigens mutually neutralize opsonic killing and protection in mice. J Clin Invest. 2010 Sep; 120(9):3220-33. PMID: 20739753.
    Citations: 26     Fields:    Translation:HumansAnimalsCells
  13. Campodónico VL, Llosa NJ, Grout M, Döring G, Maira-Litrán T, Pier GB. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect Immun. 2010 Feb; 78(2):746-55. PMID: 19995892.
    Citations: 44     Fields:    Translation:AnimalsCells
  14. Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M, Tsvetkov YE, Nifantiev NE, Pier GB. Synthetic {beta}-(1->6)-linked N-acetylated and nonacetylated oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun. 2010 Feb; 78(2):764-72. PMID: 19948836.
    Citations: 44     Fields:    Translation:HumansAnimalsCells
  15. Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009 Oct; 191(19):5953-63. PMID: 19633088.
    Citations: 135     Fields:    Translation:Cells
  16. Pérez MM, Prenafeta A, Valle J, Penadés J, Rota C, Solano C, Marco J, Grilló MJ, Lasa I, Irache JM, Maira-Litran T, Jiménez-Barbero J, Costa L, Pier GB, de Andrés D, Amorena B. Protection from Staphylococcus aureus mastitis associated with poly-N-acetyl beta-1,6 glucosamine specific antibody production using biofilm-embedded bacteria. Vaccine. 2009 Apr 14; 27(17):2379-86. PMID: 19428854.
    Citations: 18     Fields:    Translation:AnimalsCells
  17. Vergara-Irigaray M, Maira-Litrán T, Merino N, Pier GB, Penadés JR, Lasa I. Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface. Microbiology (Reading). 2008 Mar; 154(Pt 3):865-877. PMID: 18310032.
    Citations: 41     Fields:    Translation:Cells
  18. Cerca N, Jefferson KK, Maira-Litrán T, Pier DB, Kelly-Quintos C, Goldmann DA, Azeredo J, Pier GB. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2007 Jul; 75(7):3406-13. PMID: 17470540.
    Citations: 56     Fields:    Translation:HumansAnimalsCells
  19. Cerca N, Maira-Litrán T, Jefferson KK, Grout M, Goldmann DA, Pier GB. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide. Proc Natl Acad Sci U S A. 2007 May 01; 104(18):7528-33. PMID: 17446272.
    Citations: 34     Fields:    Translation:AnimalsCells
  20. Kropec A, Maira-Litran T, Jefferson KK, Grout M, Cramton SE, Götz F, Goldmann DA, Pier GB. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun. 2005 Oct; 73(10):6868-76. PMID: 16177366.
    Citations: 77     Fields:    Translation:AnimalsCells
  21. Maira-Litrán T, Kropec A, Goldmann DA, Pier GB. Comparative opsonic and protective activities of Staphylococcus aureus conjugate vaccines containing native or deacetylated Staphylococcal Poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun. 2005 Oct; 73(10):6752-62. PMID: 16177353.
    Citations: 93     Fields:    Translation:AnimalsCells
  22. Maira-Litran T, Kropec A, Goldmann D, Pier GB. Biologic properties and vaccine potential of the staphylococcal poly-N-acetyl glucosamine surface polysaccharide. Vaccine. 2004 Feb 17; 22(7):872-9. PMID: 15040940.
    Citations: 29     Fields:    Translation:HumansAnimalsCells
  23. Joyce JG, Abeygunawardana C, Xu Q, Cook JC, Hepler R, Przysiecki CT, Grimm KM, Roper K, Ip CC, Cope L, Montgomery D, Chang M, Campie S, Brown M, McNeely TB, Zorman J, Maira-Litrán T, Pier GB, Keller PM, Jansen KU, Mark GE. Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus. Carbohydr Res. 2003 Apr 22; 338(9):903-22. PMID: 12681914.
    Citations: 37     Fields:    Translation:AnimalsCells
  24. Maira-Litrán T, Kropec A, Abeygunawardana C, Joyce J, Mark G, Goldmann DA, Pier GB. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun. 2002 Aug; 70(8):4433-40. PMID: 12117954.
    Citations: 131     Fields:    Translation:AnimalsCells
  25. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol. 2002; 46:202-56. PMID: 12073654.
    Citations: 88     Fields:    Translation:Cells
  26. Maira-Litrán T, Allison DG, Gilbert P. An evaluation of the potential of the multiple antibiotic resistance operon (mar) and the multidrug efflux pump acrAB to moderate resistance towards ciprofloxacin in Escherichia coli biofilms. J Antimicrob Chemother. 2000 Jun; 45(6):789-95. PMID: 10837431.
    Citations: 18     Fields:    Translation:Cells
  27. Maira-Litrán T, Allison DG, Gilbert P. Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm. J Appl Microbiol. 2000 Feb; 88(2):243-7. PMID: 10735992.
    Citations: 10     Fields:    Translation:Cells
  28. Maira-Litran T, Allison DG, and Gilbert P . Role of MAR operon in biofilm resistance to antimicrobial agents. Wimpenny J. ed. Biofilms: The Good, The Bad and The Ugly. 1999; 317-25 .
  29. Allison D, Maira-Litran T, Gilbert P. Perfused biofilm fermenters. Methods Enzymol. 1999; 310:232-48. PMID: 10547797.
    Citations: 4     Fields:    Translation:HumansCells
  30. Gilbert, P., Jones, M.V., Allison, D.G., Heys, S., Maira-Litran, T. and Wood, P. . The use of poloxamer hydrogels for the assessment of biofilm susceptibility towards biocide treatments. J Appl Microb. 1998; 85:985-90.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Maira-Litran's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (158)
Co-Authors (16)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.